Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Smoking × Blood Specimen Collection × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 117 Neoplasms 109 Lung Neoplasms 65 Colorectal Neoplasms 52 Carcinoma, Non-Small-Cell Lung 46 Prostatic Neoplasms 45 Pancreatic Neoplasms 33 Melanoma 33 Neoplastic Cells, Circulating 29 Ovarian Neoplasms 28 Head and Neck Neoplasms 26 Uterine Cervical Neoplasms 23 Multiple Myeloma 20 Colonic Neoplasms 20 Sarcoma 19 Glioma 19 Carcinoma, Hepatocellular 19 Neoplasm Metastasis 17 Leukemia, Myeloid, Acute 17 Lymphoma 15 Esophageal Neoplasms 15 Hematologic Neoplasms 14 Glioblastoma 14 Squamous Cell Carcinoma of Head and Neck 13 Leukemia 13 Endometrial Neoplasms 13 Myelodysplastic Syndromes 11 Kidney Neoplasms 11 Gastrointestinal Neoplasms 11 Carcinoma, Renal Cell 11

Interventions

Tobacco Use Cessation Devices 5 Surveys and Questionnaires 4 Standard of Care 3 Exercise 3 Ethanol 3 Varenicline 2 Tomography, X-Ray Computed 2 Tobacco Products 2 Smoking Devices 2 Radiotherapy 2 Motivational Interviewing 2 Celecoxib 2 zileuton 1 olaparib 1 Yoga 1 Vitamin B 12 1 Videotape Recording 1 Transcranial Direct Current Stimulation 1 Tablets 1 Restraint, Physical 1 Radon 1 Psychiatric Rehabilitation 1 Preoperative Exercise 1 Practice Guidelines as Topic 1 Phlebotomy 1 Patient Navigation 1 Nutritional Support 1 Nicotine Replacement Therapy 1 Nicotine 1 Mindfulness-Based Stress Reduction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01578018 2012-08-10

Tumor Markers in Lung Cancer: DCAMLK-1LK-1

University of Oklahoma

Phase NA Completed

Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon ⚡